ABT-143
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ABT-143, covering 2012-08-01 to 2012-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg [Phase 1]